Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice - PubMed (original) (raw)
Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice
Shinsuke Taki. Cytokine Growth Factor Rev. 2002 Aug-Oct.
Abstract
Type I interferons (IFN-alpha/beta) are produced upon viral and bacterial infections and play essential roles in host defense. However, since IFN-alpha/beta have multiple regulatory functions on innate and adoptive immunity, dysregulation of the IFN-alpha/beta system both in uninfected hosts and during immune responses against infection can result in immunopathologies. In fact, IFN-alpha/beta therapy often accompanies autoimmune-like symptoms. In this regard, we have recently found that mice lacking IFN regulatory factor (IRF)-2, a negative regulator of IFN-alpha/beta signaling, develop spontaneous, CD8(+) T cell-dependent skin inflammation. This unique animal model, together with other animal models, highlights the importance of the mechanism maintaining the homeostasis in the IFN-alpha/beta system even in the absence of infection.
Similar articles
- Genetic control directed toward spontaneous IFN-alpha/IFN-beta responses and downstream IFN-gamma expression influences the pathogenesis of a murine psoriasis-like skin disease.
Arakura F, Hida S, Ichikawa E, Yajima C, Nakajima S, Saida T, Taki S. Arakura F, et al. J Immunol. 2007 Sep 1;179(5):3249-57. doi: 10.4049/jimmunol.179.5.3249. J Immunol. 2007. PMID: 17709541 - CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling.
Hida S, Ogasawara K, Sato K, Abe M, Takayanagi H, Yokochi T, Sato T, Hirose S, Shirai T, Taki S, Taniguchi T. Hida S, et al. Immunity. 2000 Nov;13(5):643-55. doi: 10.1016/s1074-7613(00)00064-9. Immunity. 2000. PMID: 11114377 - Type I IFN protects against murine lupus.
Hron JD, Peng SL. Hron JD, et al. J Immunol. 2004 Aug 1;173(3):2134-42. doi: 10.4049/jimmunol.173.3.2134. J Immunol. 2004. PMID: 15265950 - New lessons about old molecules: how type I interferons shape Th1/Th17-mediated autoimmunity in the CNS.
Prinz M, Kalinke U. Prinz M, et al. Trends Mol Med. 2010 Aug;16(8):379-86. doi: 10.1016/j.molmed.2010.06.001. Epub 2010 Jun 28. Trends Mol Med. 2010. PMID: 20591737 Review. - Transcription factors in interferon signaling.
David M. David M. Pharmacol Ther. 1995 Feb;65(2):149-61. doi: 10.1016/0163-7258(94)00050-d. Pharmacol Ther. 1995. PMID: 7540766 Review.
Cited by
- Interferon regulatory factor 6 (IRF6) determines intestinal epithelial cell development and immunity.
Wright AP, Harris S, Madden S, Reyes BR, Mulamula E, Gibson A, Rauch I, Constant DA, Nice TJ. Wright AP, et al. Mucosal Immunol. 2024 Aug;17(4):633-650. doi: 10.1016/j.mucimm.2024.03.013. Epub 2024 Apr 9. Mucosal Immunol. 2024. PMID: 38604478 Free PMC article. - Differential Regulation of Type I and Type III Interferon Signaling.
Stanifer ML, Pervolaraki K, Boulant S. Stanifer ML, et al. Int J Mol Sci. 2019 Mar 21;20(6):1445. doi: 10.3390/ijms20061445. Int J Mol Sci. 2019. PMID: 30901970 Free PMC article. Review. - Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion.
Li MM, Bozzacco L, Hoffmann HH, Breton G, Loschko J, Xiao JW, Monette S, Rice CM, MacDonald MR. Li MM, et al. J Exp Med. 2016 Dec 12;213(13):2931-2947. doi: 10.1084/jem.20160303. Epub 2016 Nov 29. J Exp Med. 2016. PMID: 27899441 Free PMC article. - Cytokines: the future of intranasal vaccine adjuvants.
Thompson AL, Staats HF. Thompson AL, et al. Clin Dev Immunol. 2011;2011:289597. doi: 10.1155/2011/289597. Epub 2011 Jul 31. Clin Dev Immunol. 2011. PMID: 21826181 Free PMC article. Review. - Type 1 diabetes and interferon therapy: a nationwide survey in Japan.
Nakamura K, Kawasaki E, Imagawa A, Awata T, Ikegami H, Uchigata Y, Kobayashi T, Shimada A, Nakanishi K, Makino H, Maruyama T, Hanafusa T; Research Committee on Type 1 Diabetes of the Japan Diabetes Society. Nakamura K, et al. Diabetes Care. 2011 Sep;34(9):2084-9. doi: 10.2337/dc10-2274. Epub 2011 Jul 20. Diabetes Care. 2011. PMID: 21775762 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials